Qiagen N.V. (QGEN) Financials
QGEN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 5.9 billion | 2.2 billion |
| 2023-06-30 | 6.3 billion | 2.7 billion |
| 2023-03-31 | 6.3 billion | 2.7 billion |
QGEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 83.6 million | 13.1 million |
| 2023-06-30 | 80.3 million | 7.9 million |
| 2023-03-31 | 33.5 million | 14.1 million |
QGEN Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 97.7 million |
| 2023-09-30 | 77.8 million |
| 2023-06-30 | 80.8 million |
| 2023-03-31 | 85.0 million |
QGEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 1.0 billion | - | - |
| 2023-06-30 | 1.3 billion | - | - |
| 2023-03-31 | 1.3 billion | - | - |
QGEN Shares Outstanding
QGEN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 41.0 million | 47.9 million | 28.6 million | 111.5 million |
| 2023-06-30 | 31.1 million | 49.9 million | 29.2 million | 116.3 million |
| 2023-03-31 | 38.4 million | 54.7 million | 32.9 million | 114.6 million |
QGEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 475.9 million | 177.9 million |
| 2023-06-30 | 494.9 million | 182.7 million |
| 2023-03-31 | 485.4 million | 177.9 million |
QGEN
Price: $42.30
52 week price:
5-year range yield:
Forward Dividend Yield: 3.17%
Payout Ratio: 86.25%
Payout Ratio Range:
Dividend Per Share: 1.32 USD
Earnings Per Share: 1.53 USD
P/E Ratio: 29.08
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 670300
Ebitda: 103.6 millionMarket Capitalization: 9.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 1